Health Idea Now
Friday, 1 March 2019
ImmunoGen's ovarian cancer drug fails in late-stage study
U.S. drug developer ImmunoGen Inc said on Friday its experimental ovarian cancer drug failed to meet the main goal of a late-stage study.
from Reuters: Health News https://ift.tt/2TrxjzK
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment